← Open Payments lookup

TONI DELMONTE: Open Payments

NPI 1851098750 · MENIFEE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,907 in 92 payments from 12 companies in 2025. Trend: 2023 $350 · 2024 $1,220 · 2025 $1,907

Food & beverage: $1,907
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)19$521
Neurocrine BioSciences, Inc.11$191
Alkermes, Inc.9$184
E.R. Squibb & Sons, L.L.C.9$174
Vanda Pharmaceuticals Inc.8$173
Otsuka America Pharmaceutical, Inc.9$167
ABBVIE INC.6$136
Teva Pharmaceuticals USA, Inc.10$135
Supernus Pharmaceuticals, Inc.4$83
Lundbeck LLC4$82

Products named: CAPLYTA, REXULTI, INGREZZA, COBENFY, VRAYLAR, ARISTADA, HETLIOZ, AUSTEDO XR.

Industry payments across CA — which companies pay providers there.